Latest Share Consolidations News

EVE Health Group has launched a $1.5 million capital raise alongside the acquisition of biotech firm Nextract, aiming to expand its footprint in health and pharmaceutical products focused on erectile dysfunction and period pain.

Patrys Limited has raised $358,362 through a share placement and announced significant board changes, including the appointment of Dr Anton Uvarov and Mr Peter Christie, alongside making the CEO role redundant.

Conico Ltd has resolved a significant legal dispute with Cartwright Drilling and announced a $2.09 million recapitalisation plan involving convertible loans, a rights offer, and a share consolidation, all pending shareholder approval.

Genetic Technologies Limited has signed binding term sheets to acquire Ellerfield Wealth and Walker Capital, marking a strategic shift into wealth management backed by a $7.8 million valuation and pending ASX approvals.

Beacon Minerals Limited has announced a proposed 40, 1 share consolidation aimed at creating a more effective capital structure and enhancing its share price appeal. The move awaits shareholder approval at the July 7 general meeting.

Beacon Minerals Limited has announced plans for a significant 40-for-1 consolidation of its shares and options, pending shareholder approval in July 2025. This move aims to streamline the capital structure and adjust option exercise prices accordingly.

Lanthanein Resources is set to raise $2.4 million through a placement and a fully underwritten rights issue, while proposing a strategic name change and share consolidation to streamline its capital structure.

Talius Group Limited has secured shareholder approval to consolidate its shares on a 10-for-1 basis, aiming to better align its capital structure with industry peers. The move affects all ordinary shares and performance rights, effective June 4, 2025.

Adavale Resources plans a significant 20:1 share consolidation to streamline its capital structure and attract institutional investors, coinciding with promising exploration progress at its Parkes Gold and Copper Project.

OncoSil Medical has launched a $8.7 million capital raising via a Share Purchase Plan and Placement, seeking shareholder approval for options issuance and a 400:1 share consolidation.

OncoSil Medical has secured $8.7 million through a placement and share purchase plan to fund commercialization of its pancreatic cancer treatment device, aiming for positive cash flow by mid-2026. Near-completion clinical trials could soon unlock broader market access.

Trinex Minerals is set to seek shareholder approval for a significant 127:1 share consolidation aimed at streamlining its capital structure and enhancing investor appeal. The move also adjusts options and performance rights accordingly.